Shareholders Approve Regularization of Ms. Vinita Gadhavi as Non-Executive Independent Director
At the 19th AGM held on 29 September 2026, shareholders approved the regularization of Ms. Vinita Shivraj Gadhavi from Additional Director to Non-Executive Independent Director for a term of 5 consecutive years.
- Director Name
- Ms. Vinita Shivraj Gadhavi
- Position Change
- From Additional Director to Non-Executive Independent Director
- Term Duration
- 5 consecutive years, effective 31 July 2026 to 30 July 2031
- Experience
- Over 12 years of experience across pharmaceuticals and healthcare innovation
- AGM Date
- 29 September 2026
What happened
At the 19th Annual General Meeting held on Tuesday, 29 September 2026 (10:00 A.M. to 11:00 A.M.), shareholders approved the regularization of Ms. Vinita Shivraj Gadhavi as a Non-Executive Independent Director.
- Change: from Additional Director to Non-Executive Independent Director
- Term: 5 consecutive years, from 31 July 2026 to 30 July 2031
- She will not be liable to retire by rotation during her tenure
- The move followed a recommendation of the Nomination and Remuneration Committee and approval of the Board
Background on the appointee
- Over 12 years of experience across pharmaceuticals, healthcare innovation, consumer brands, quality systems, research and strategic growth
- Holds a Ph.D. focused on the Indian Healthcare Startup Ecosystem, an MBA in Total Quality Management and a B. Pharm; Gold Medal for M. Pharm in Quality Assurance from Gujarat Technological University
- Focus areas include quality assurance, regulatory compliance, business development and R&D commercialization
- Recognized with innovation grants from SSIP, GUSEC and i-Hub Gujarat; won the State-Level HerSTART Entrepreneurship Competition
Other disclosures
- She is not related to any other existing Director of the Company
- She is not debarred from holding office of a Director by any SEBI or other authority order
What it means for investors
This is a board-composition matter. An Additional Director appointed by the Board holds office only until the next general meeting, so shareholder approval formalises her position for the stated five-year term. It does not, by itself, change the company's operations or finances.
More numbers
- Term of appointment5 (five) consecutive years
- Experience of appointeeover 12 years of experience
- AGM number19th Annual General Meeting
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.